FLCCC | 16 Sep 2021
Below you can download the I-MASK+ Prevention & Early Outpatient Treatment Protocol for COVID-19 with guidance on the timing and doses of each component medication. Further below please find more information on the I-MASK+ Protocol.
The I-MASK+ Protocol complements our MATH+ Hospital Treatment Protocol for Covid-19 from March 2020, which is intended for hospitalized patients. Both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All component medicines are FDA-approved, inexpensive, readily available and have been used for decades with well-established safety profiles. In October 2020, we added ivermectin as a core medication in the prevention and treatment of COVID-19.
The protocol document is available in several languages (see below) – more translations are available here. This is not a medical advice, but a recommendation – please consult your doctor, share the information on this website with her/him, and listen. Please review our Disclaimers!
Please check this page regularly for updates – new medications may be added and/or dose changes to existing medications may be made as further scientific studies emerge.
Current I-MASK+ protocol: version 16, updated on September 1, 2021 (English version, translation updates follow).
